Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/recent-advancements-in-the-diagnosis-of-human-disease/descriptif_5082771
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=5082771

Recent Advancements in the Diagnosis of Human Disease

Langue : Anglais

Coordonnateur : M. Sulaiman Irshad

Couverture de l’ouvrage Recent Advancements in the Diagnosis of Human Disease

Viruses, bacteria, fungi and parasites are known to cause the most common human disease. It frequently spreads through direct contact (from human to human, animal to human), and through contaminated food or water. With the advancement of diagnostic techniques, it is now possible to rapidly identify microorganisms causing human disease and correlate with the corresponding clinical infection. Therefore, there is a need to develop robust and high-throughput diagnostic methods to prevent and control human disease of public health importance. This book entitled ?Recent Advancements in the Diagnosis of Human Disease? will help the scientific community to better understand the transmission dynamics of some human diseases.

Preface. AI-Powered Laboratory Diagnostics Technology. Detection of Gastrointestinal Protists. Methods Used for Diagnosis of Malaria and their Strengths and Limitations. Advances in the Diagnosis of Filarial Nematodes. Diagnosis and Treatment of Acute Lung Injury: Understanding the Molecular Mechanisms. MALDI-TOF MS Fingerprinting for the Diagnosis of Infectious Diseases. Proteomics Fundamentals and Applications in Microbiology. Methods for Multiplex Real-Time PCR Melting Curve Assays for Pathogen Detection. Persistence and Biofilm Formation of Foodborne Bacterial Pathogens on Fresh Produce and Equipment Surfaces. Index.

Academic, Postgraduate, and Undergraduate Advanced

Dr. Irshad M. Sulaiman has been involved in the area of biomedical research focusing on the control and prevention of human-pathogenic microorganisms of public health importance, for over three decades. He obtained his PhD from Delhi University. Dr. Sulaiman joined the U.S. CDC in 1997, and worked until 2008. Since 2008, he is with the U.S. FDA. Dr. Sulaiman has characterized a large number of emerging infectious microbial pathogens isolated from various sources. He has developed several novel molecular diagnostic methods, described several new species and genotypes, and published over 96 peer-reviewed manuscripts.

Ces ouvrages sont susceptibles de vous intéresser